Effect of sitagliptin on intrahepatic lipid content and body fat in patients with type 2 diabetes. Issue 1 (July 2015)

• Record Type: Journal Article
• Authors: Kato, Hiroyuki; Nagai, Yoshio; Ohta, Akio; Tenjin, Ayumi; Nakamura, Yuta; Tsukiyama, Hidekazu; Sasaki, Yosuke; Fukuda, Hisashi; Ohshige, Toshihiko; Terashima, Yuko; Sada, Yukiyoshi; Kondo, Akihiko; Sasaoka, Toshiyasu; Tanaka, Yasushi
• Is Part Of: Diabetes research and clinical practice. Volume 109:Issue 1(2015)
• Page Start: 199
• Page End: 205
• Publication Date: 2015-07
• Subjects: Diabetes -- Periodicals; Diabetes Mellitus -- Periodicals; 616.462
• DOI: 10.1016/j.diabres.2015.04.008
• Languages: English
• ISSNs: 0168-8227

Abstract

<abstract abstract-type="author-highlights" id="abs0005"> <title id="sect0005">Highlights</title> <sec> <p id="spar0005"> <list id="lis0005"> <list-item id="lsti0005"> <label></label> <p id="par0005">The subjects were Japanese patients with T2DM with a BMI ≥ 25 kg/m2 or fatty liver.</p> </list-item> <list-item id="lsti0010"> <label></label> <p id="par0010">A prospective, 24-week, single-center, open-label comparative study enrolled.</p> </list-item> <list-item id="lsti0015"> <label></label> <p id="par0015">Treatment with sitagliptin or glimepiride reduced HbA1c and GA similarly.</p> </list-item> <list-item id="lsti0020"> <label></label> <p id="par0020">After 24 weeks, only sitagliptin decreased IHL and total body fat mass.</p> </list-item> </list> </p> </sec> </abstract>